tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market
INKT
MiNK Therapeutics
RESEARCH TOOLSreports
Want to see INKT full AI Analyst Report?

MiNK Therapeutics (INKT) Financial Statements

265 Followers

MiNK Therapeutics Financial Overview

MiNK Therapeutics's market cap is currently $64.26M. The company's EPS TTM is $-0.52; its P/E ratio is -3.81; MiNK Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -181.75K$ -215.44K$ -204.62K$ -121.75K$ -77.96K
Operating Income$ -12.49M$ -10.65M$ -22.92M$ -30.95M$ -18.61M
EBITDA$ -12.31M$ -10.57M$ -22.25M$ -27.87M$ -27.70M
Net Income$ -12.49M$ -10.78M$ -22.46M$ -27.99M$ -30.21M
Balance Sheet
Cash & Short-Term Investments$ 13.36B$ 4.58M$ 3.37M$ 19.64M$ 38.89M
Total Assets$ 14.24M$ 5.72M$ 4.55M$ 21.47M$ 40.24M
Total Debt$ 5.18M$ 4.92M$ 0.00$ 0.00$ 0.00
Net Debt$ -13.36B$ 347.57K$ -3.37M$ -19.64M$ -38.89M
Total Liabilities$ 28.47M$ 25.31M$ 22.61M$ 21.87M$ 16.47M
Stockholders' Equity$ -14.23M$ -19.59M$ -18.06M$ -401.30K$ 23.78M
Cash Flow
Free Cash Flow$ -5.93B$ -9.56M$ -15.84M$ -19.12M$ -13.08M
Operating Cash Flow$ -5.93B$ -9.56M$ -15.76M$ -18.87M$ -12.83M
Investing Cash Flow$ 0.00$ 0.00$ -73.56K$ -250.05K$ -248.98K
Financing Cash Flow$ 14.72B$ 10.82M$ -407.17K$ -155.60K$ 49.26M
Currency in USD

MiNK Therapeutics Earnings and Revenue History

Income Statement >

MiNK Therapeutics Debt to Assets

Balance Sheet >

MiNK Therapeutics Cash Flow

Cash Flow >

MiNK Therapeutics Forecast EPS vs Actual EPS

Earnings >